Skip to main content
. 2022 Jul 13;11(3):1375–1390. doi: 10.1007/s40120-022-00384-2

Fig. 3.

Fig. 3

TSQM outcomes in whole patient cohort at 12 and 24 months versus baseline. Wilcoxon signed-rank test; #p = 0.02, ++p < 0.001 and &p < 0.0001 versus baseline